DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ shed 1.52% to $8.40 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.51% to 19,630.20 and the Dow Jones Industrial Average rising 0.78% to 43,487.83.
This was the stock's second consecutive day of losses.
Novavax Inc. closed 64.79% below its 52-week high of $23.86, which the company reached on June 6th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.50% to $147.03, Pfizer Inc. $(PFE)$ fell 0.72% to $26.30, and Merck & Co. Inc. $(MRK)$ fell 2.76% to $97.92.
Data source: Dow Jones Market Data, FactSet. Data compiled January 17, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 17, 2025 17:31 ET (22:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。